Shanghai OPM Biosciences Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 146.71 million compared to CNY 82.39 million a year ago. Revenue was CNY 146.72 million compared to CNY 82.39 million a year ago.

Net income was CNY 53.36 million compared to CNY 18.96 million a year ago. Basic earnings per share from continuing operations was CNY 0.6214 compared to CNY 0.2214 a year ago. Diluted earnings per share from continuing operations was CNY 0.6214 compared to CNY 0.2214 a year ago.